Copyright
©The Author(s) 2025.
World J Diabetes. Nov 15, 2025; 16(11): 111280
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.111280
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.111280
Figure 1 Literature search and screening flowchart.
RCT: Randomized controlled trial.
Figure 2 Results of major adverse cardiovascular events.
A: Comparison network results for major adverse cardiovascular events (MACEs) of three classes of drugs; B: Comparison network results for MACEs of different drugs; C: Forest plot for MACEs of three classes of drugs; D: Forest plot for MACEs of different drugs.
Figure 3 Results of all-cause mortality.
A: Comparison network results for all-cause mortality of three classes of drugs; B: Comparison network results for all-cause mortality of different drugs; C: Forest plot for all-cause mortality of three classes of drugs; D: Forest plot for all-cause mortality of different drugs.
Figure 4 Results of cardiovascular mortality.
A: Comparison network results for cardiovascular mortality of three classes of drugs; B: Comparison network results for cardiovascular mortality of different drugs; C: Forest plot for cardiovascular mortality of three classes of drugs; D: Forest plot for cardiovascular mortality of different drugs.
Figure 5 Results of composite renal events.
A: Comparison network results for composite renal events of three classes of drugs; B: Comparison network results for composite renal events of different drugs; C: Forest plot for composite renal events of three classes of drugs; D: Forest plot for composite renal events of different drugs.
Figure 6 Results of progression of proteinuria.
A: Comparison network results for progression of proteinuria of three classes of drugs; B: Comparison network results for progression of proteinuria of different drugs; C: Forest plot for progression of proteinuria of three classes of drugs; D: Forest plot for progression of proteinuria of different drugs.
Figure 7 Results of renal replacement therapy.
A: Comparison network results for renal replacement therapy of three classes of drugs; B: Comparison network results for renal replacement therapy of different drugs; C: Forest plot for renal replacement therapy of three classes of drugs; D: Forest plot for renal replacement therapy of different drugs.
Figure 8 Results of serious adverse events.
A: Comparison network results for serious adverse events of three classes of drugs; B: Comparison network results for serious adverse events of different drugs; C: Forest plot for serious adverse events of three classes of drugs; D: Forest plot for serious adverse events of different drugs.
Figure 9 Results of diabetic ketoacidosis.
A: Comparison network results for diabetic ketoacidosis of three classes of drugs; B: Comparison network results for diabetic ketoacidosis of different drugs; C: Forest plot for diabetic ketoacidosis of three classes of drugs; D: Forest plot for diabetic ketoacidosis of different drugs.
Figure 10 Results of pancreatitis.
A: Comparison network results for pancreatitis of three classes of drugs; B: Comparison network results for pancreatitis of different drugs; C: Forest plot for pancreatitis of three classes of drugs; D: Forest plot for pancreatitis of different drugs.
- Citation: An XD, Li XQ, Zhang H, Jia QY, Zhang YH, Yang GG. Comparison of three types of drugs for cardiovascular and renal benefits in type 2 diabetes mellitus. World J Diabetes 2025; 16(11): 111280
- URL: https://www.wjgnet.com/1948-9358/full/v16/i11/111280.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i11.111280
